当前位置:
X-MOL 学术
›
Aliment. Pharm. Ther.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Systematic review and meta-analysis: efficacy and safety of early biologic treatment in adult and paediatric patients with Crohn's disease.
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2020-03-23 , DOI: 10.1111/apt.15685 Ryan C Ungaro 1 , Saurabh Aggarwal 2 , Ozlem Topaloglu 2 , Wan-Ju Lee 3 , Ryan Clark 3 , Jean-Frederic Colombel 1
Alimentary Pharmacology & Therapeutics ( IF 6.6 ) Pub Date : 2020-03-23 , DOI: 10.1111/apt.15685 Ryan C Ungaro 1 , Saurabh Aggarwal 2 , Ozlem Topaloglu 2 , Wan-Ju Lee 3 , Ryan Clark 3 , Jean-Frederic Colombel 1
Affiliation
There is an increasing body of evidence showing that earlier use of biologics improves clinical outcomes in Crohn's disease (CD).
中文翻译:
系统评价和荟萃分析:成人和儿童克罗恩病患者早期生物治疗的有效性和安全性。
越来越多的证据表明,早期使用生物制剂可改善克罗恩病 (CD) 的临床结果。
更新日期:2020-04-22
中文翻译:
系统评价和荟萃分析:成人和儿童克罗恩病患者早期生物治疗的有效性和安全性。
越来越多的证据表明,早期使用生物制剂可改善克罗恩病 (CD) 的临床结果。